Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.35 USD | -7.67% | -11.16% | -15.51% |
Business Summary
Number of employees: 118
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 04-03-25 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 21-05-02 |
Ryan Baker
IRC | Investor Relations Contact | - | 23-04-30 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 23-07-24 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 16-10-31 |
Mike Smith
PRN | Corporate Officer/Principal | - | 16-01-31 |
Rachel Morten
LAW | General Counsel | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 19-01-31 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Albert Cha
BRD | Director/Board Member | 51 | 15-12-31 |
Edward Unkart
BRD | Director/Board Member | 74 | 14-11-30 |
Nancy Stuart
BRD | Director/Board Member | 65 | 21-03-17 |
Patrick Treanor
BRD | Director/Board Member | - | 22-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,188,296 | 41,706,792 ( 98.86 %) | 0 | 98.86 % |
Company contact information
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.51% | 437M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.17% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
-0.22% | 8.31B |
- Stock Market
- Equities
- KALV Stock
- Company KalVista Pharmaceuticals, Inc.